These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 12228918

  • 1. Matrix metalloproteinases and collagen catabolism.
    Lauer-Fields JL, Juska D, Fields GB.
    Biopolymers; 2002; 66(1):19-32. PubMed ID: 12228918
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines.
    Heinz A, Jung MC, Duca L, Sippl W, Taddese S, Ihling C, Rusciani A, Jahreis G, Weiss AS, Neubert RH, Schmelzer CE.
    FEBS J; 2010 Apr; 277(8):1939-56. PubMed ID: 20345904
    [Abstract] [Full Text] [Related]

  • 6. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
    Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Visse R, Nagase H, Fields GB.
    J Biol Chem; 2006 Dec 15; 281(50):38302-13. PubMed ID: 17065155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase substrate binding domains, modules and exosites. Overview and experimental strategies.
    Overall CM.
    Methods Mol Biol; 2001 Dec 15; 151():79-120. PubMed ID: 11217327
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ, Stawikowska R, Fields GB.
    Biochemistry; 2015 May 19; 54(19):3110-21. PubMed ID: 25897652
    [Abstract] [Full Text] [Related]

  • 12. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
    Overall CM.
    Mol Biotechnol; 2002 Sep 19; 22(1):51-86. PubMed ID: 12353914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M, Miyamori H, Yamashita J, Sato H.
    Cancer Res; 2003 Jun 15; 63(12):3364-9. PubMed ID: 12810672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MMP-1: the elder of the family.
    Pardo A, Selman M.
    Int J Biochem Cell Biol; 2005 Feb 15; 37(2):283-8. PubMed ID: 15474975
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.
    Am J Hypertens; 2004 Sep 15; 17(9):775-82. PubMed ID: 15363819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.